KRISTEN NEW: Open Payments
NPI 1952054223 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 11 payments from 6 companies in 2025. Trend: 2023 $115 · 2024 $541 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| QOL Medical, LLC | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: REZDIFFRA, ENTYVIO, Sucraid, ZENPEP, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
